Cosmetic cross-reference Noindex: medium evidence

Chicory, ext.

CAS 68650-43-1

Chicory, ext. (CAS 68650-43-1) is a pharmaceutical compound with 0 bioactivity targets and 15 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
15
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EPA DSSTox

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Chicory, ext.
CAS Number
68650-43-1
Source Match
EPA DSSTox
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE DSSTox identifiers DTXSID301009822

Cross-Reference to Chemicals

Same-CAS substance identity is available in the industrial chemicals vertical.

Chicory, ext. is linked to DTXSID301009822 in DSSTox identifiers.

View industrial chemical data →
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Chicory, ext. used for in pharmaceutical contexts?

Chicory, ext. (CAS 68650-43-1) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Chicory, ext.?

Chicory, ext. has 15 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Arthralgia, Balance disorder, Dermatitis atopic, Fatigue, Hepatic enzyme increased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Chicory, ext. also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Cichorium Intybus Flower Extract with EU status "permitted".

What clinical phase is Chicory, ext. in?

No phase 1-4 clinical development badge is rendered for Chicory, ext. because the matched compound identifier rows do not contain a max-phase value.